KLOW Blend Overview: Extended Repair Peptide Research Combinations
Published 2026-06-11 · 6 min read
KLOW is an extended combination research blend in the repair-peptide category. The general design pattern is to start from a GLOW-style copper-and-repair core (copper tripeptide, BPC-157, TB-500) and add an anti-inflammatory tripeptide arm that operates through a receptor-independent mechanism. The result is a multi-component vial that covers more of the repair-and-inflammation literature in a single reconstitution.
This overview explains the rationale behind extended repair blends, the additional research angle that the anti-inflammatory tripeptide arm contributes, and the practical considerations that matter when working with multi-component vials. For the exact composition and mass-per-component of the KLOW vial sold by Kalon Research, refer to the product page.
The pattern: GLOW plus an anti-inflammatory arm
GLOW-style blends cover three repair arms — cytoprotection and growth-factor support, actin sequestration and angiogenesis, and copper-dependent matrix biology. What that core does not directly address is NF-κB-driven inflammatory tone in surrounding tissue. The most-studied minimal anti-inflammatory tripeptide in the literature is KPV, the C-terminal fragment of α-MSH, which dampens NF-κB activation through a melanocortin-receptor-independent mechanism. Pairing KPV with the GLOW core extends the research model coverage from repair signaling alone to repair plus inflammatory tone.
For background on the underlying GLOW pattern, see the GLOW Blend Overview.
Constituent compound categories
In the published research on extended repair-blend formulations, the compound categories typically represented in KLOW-style products are:
- Anti-inflammatory tripeptide — KPV — α-MSH C-terminal fragment; receptor-independent NF-κB-suppressive activity in published models.
- Copper tripeptide — GHK-Cu — copper-dependent matrix and skin-research biology.
- Cytoprotective pentadecapeptide — BPC-157 — cytoprotection and growth-factor support. See How to Reconstitute BPC-157.
- Actin-sequestering thymosin fragment — TB-500. Comparison with BPC-157 in the BPC-157 vs TB-500 article.
The exact composition and mass-per-component of the specific KLOW vial available from Kalon Research is shown on the product page.
When to choose KLOW over GLOW
- Inflammation is in the model: when the research question involves NF-κB-driven inflammatory tone in surrounding tissue, not only repair pathway recruitment.
- Mucosal models:KPV's PEPT1-mediated uptake in intestinal epithelium makes it particularly relevant to gut-mucosal research models.
- Combined repair plus dermal-inflammation work: skin models where matrix biology and local inflammatory tone are both endpoints of interest.
When GLOW is sufficient
- Pure repair-pathway research: when the model is focused on cytoprotection, angiogenesis, and matrix biology without a separate inflammatory arm.
- Independent KPV dose ranging: when anti-inflammatory dose-response needs to be titrated separately from repair components.
Lab handling
Lyophilized extended blends are stable at −20°C for typical research timeframes. Standard repair-peptide practice applies: gentle swirling rather than shaking on reconstitution, aliquoting before freezing, and limiting freeze-thaw cycles. Because KLOW carries more total mass per vial than GLOW, reconstitution volumes are typically larger to keep working concentrations comfortable on a U-100 syringe.
For step-by-step reconstitution that applies to extended repair blends, see How to Reconstitute BPC-157. For pre-computed concentration math at the blend vial size, use the Reconstitution Calculator.
For Research Use Only. Information presented for laboratory and research applications. Not medical advice and not a substitute for qualified scientific judgment. Kalon Research does not provide identity, purity, or quality control documentation with shipments. Buyer assumes all responsibility.